3B BLACKBIO DX LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | UnAudited |
Net Sales | 176.69 | 191.76 | 142.82 | 181.1 |
Total Expenditure | 87.94 | 113.89 | 78.42 | 106.48 |
PBIDT (Excl OI) | 88.75 | 77.87 | 64.4 | 74.62 |
Other Income | 26.28 | 27.5 | 29.61 | 11.54 |
Operating Profit | 115.03 | 105.36 | 94.01 | 86.16 |
Interest | 0.28 | 0.38 | 0.17 | 0.44 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 114.75 | 104.98 | 93.84 | 85.72 |
Depreciation | 3.22 | 2.38 | 1.93 | 2.08 |
Profit Before Tax | 111.53 | 102.6 | 91.91 | 83.64 |
Tax | 26.35 | 26.73 | 19.85 | 31.66 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 85.18 | 75.87 | 72.06 | 51.98 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 85.18 | 75.87 | 72.06 | 51.98 |
Minority Interest | 2.08 | 2.67 | -9.08 | -6.88 |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 87.25 | 78.55 | 62.99 | 45.09 |
Equity Capital | 85.68 | 85.66 | 75.08 | 75.08 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | 1626.76 | 1626.76 | 1455.33 | 1455.33 |
Calculated EPS | 10.18 | 9.16 | 8.38 | 6.00 |
Calculated EPS (Annualised) | 40.73 | 36.67 | 33.55 | 24.02 |
No of Public Share Holdings | 4622752 | 4622752 | 4622752 | 4622752 |
% of Public Share Holdings | 61.57 | 61.57 | 61.57 | 61.57 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 50.22 | 40.60 | 45.09 | 41.20 |
PBIDTM% | 65.10 | 54.94 | 65.82 | 47.57 |
PBDTM% | 64.94 | 54.74 | 65.70 | 47.33 |
PBTM% | 63.12 | 53.50 | 64.35 | 46.18 |
PATM% | 48.20 | 39.56 | 50.45 | 28.70 |
"; | Notes | Notes | Notes | Notes |